Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tetralogic Pharma (TLOG)
OTHER OTC:TLOG
Tetralogic Pharma (TLOG) Stock Price & Analysis
21 Followers
TLOG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.01
Previous Close$0.01
Volume30.00
Average Volume (3M)N/A
Market Cap
$2.45K
Enterprise Value$24.93M
Total Cash (Recent Filing)$5.89M
Total Debt (Recent Filing)$30.81M
Price to Earnings (P/E)N/A
Beta0.76
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.83
R-Squared0.04
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
46.72%
Insiders
0.00% Mutual Funds
0.02% Other Institutional Investors
53.27% Public Companies and
Individual Investors
TLOG FAQ
What was Tetralogic Pharma’s price range in the past 12 months?
Tetralogic Pharma lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Tetralogic Pharma’s market cap?
Currently, no data Available
When is Tetralogic Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tetralogic Pharma’s earnings last quarter?
Currently, no data Available
Is Tetralogic Pharma overvalued?
According to Wall Street analysts Tetralogic Pharma’s price is currently Overvalued.
Does Tetralogic Pharma pay dividends?
Tetralogic Pharma does not currently pay dividends.
What is Tetralogic Pharma’s EPS estimate?
Tetralogic Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tetralogic Pharma have?
Tetralogic Pharma has 24,465,000 shares outstanding.
What happened to Tetralogic Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tetralogic Pharma?
Currently, no hedge funds are holding shares in TLOG
---
Company Description
Tetralogic Pharma
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
---
Technical Analysis
---